REN and diabetic kidney disease: Whilst renin–angiotensin–aldosterone system blockade has been the backbone of DKD treatment over the last two decades [3], a significant residual risk of progressive renal disease and accelerated cardiovascular disease has remained in people with DKD despite intensive treatment [4].